Cargando…
Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
Autores principales: | Hobl, Eva-Luise, Jilma, Bernd, Erlacher, Ludwig, Mader, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016546/ http://dx.doi.org/10.1186/1471-2210-10-S1-A35 |
Ejemplares similares
-
Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis
por: Yamamoto, Tatsuhiro, et al.
Publicado: (2016) -
Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study
por: Takahashi, Chihiro, et al.
Publicado: (2017) -
A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis
por: van de Meeberg, Maartje M., et al.
Publicado: (2022) -
Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial
por: Pasnoor, Mamatha, et al.
Publicado: (2020) -
Correlation between serum methotrexate-polyglutamate 3 (MTX-PG3) level and disease activity in rheumatoid arthritis patients: A prospective cohort study
por: Musdalita, Eva, et al.
Publicado: (2022)